79366679 - BIFIBABY

Information

  • Trademark
  • 79366679
  • Serial Number
    79366679
  • Registration Number
    7525581
  • Filing Date
    February 17, 2023
    a year ago
  • Registration Date
    October 08, 2024
    4 months ago
  • Transaction Date
    January 08, 2025
    a month ago
  • Status Date
    October 08, 2024
    4 months ago
  • Published for Opposition Date
    July 23, 2024
    6 months ago
  • Location Date
    October 07, 2024
    4 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    O'BRIEN, JENNIFER
  • Attorney Docket Number
    MARB-69637
    Attorney Name
    Michelle E. Tochtrop
  • Owners
Mark Drawing Code
4
Mark Identification
BIFIBABY
Case File Statements
  • GS0051: Micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and to reared animal species, for medical and veterinary use; micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, anallergic bifidobacterium probiotic bacteria which has beneficial activity on the intestinal microflora of babies; proprietary medicine containing micro-organisms and cultures of micro-organisms, in particular probiotic preparations for medical use in the nature of probiotic lactic bacteria, bifidobacterium probiotic bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, in particular in diseases linked to changes in the bacterial flora such as diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, to be taken orally, in particular in the form of capsules, tablets, solutions, suspensions, granules and granules in dried or freeze-dried form; food supplements, food supplements for medical use containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings; dietary supplements; food supplements containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and reared animal species, not for medical or veterinary use; symbiotic dietary supplements containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria and prebiotic fibres; food supplements for animals, not for medical use
  • GS0011: Micro-organisms and cultures of micro-organisms, in particular bacteria for use in food manufacture, bifidobacterium probiotic bacteria for use in the manufacture of food supplements, food, medical preparations, yeast nutrients for industrial purposes and fermented milk products in the nature of milk ferments for industrial purposes; micro-organisms and cultures of microorganisms, in particular probiotic lactic bacteria, bifidobacterium probiotic bacteria to be administered to human beings and reared animal species, not for medical or veterinary use for use in the manufacture of food supplements, food, medical preparations; micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form, namely, probiotic bacteria for use in the manufacture of food supplements, food, medical preparations
Case File Event Statements
  • 4/3/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/31/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Type: SDRC
  • 4/7/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/6/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/13/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/13/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/12/2024 - 8 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/12/2024 - 8 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/16/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/5/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/7/2024 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/12/2024 - 8 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/14/2024 - 8 months ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/3/2024 - 7 months ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/23/2024 - 6 months ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/23/2024 - 6 months ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/28/2024 - 5 months ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 8/28/2024 - 5 months ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 9/14/2024 - 5 months ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 10/8/2024 - 4 months ago
    20 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/8/2024 - 4 months ago
    21 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 1/8/2025 - a month ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR